Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 3:27 PM ET

Healthcare Equipment and Supplies

Company Overview of Ulthera, Inc.

Company Overview

Ulthera, Inc., a medical device company, develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technology. The company offers Ulthera System, an energy-based device for non-invasive aesthetic lift indication, which is used in Ultherapy, a procedure that lifts the skin above the eyebrows, on the neck, and under the chin. It provides its products through representatives and distributors worldwide. The company was founded in 2004 and is headquartered in Mesa, Arizona. As of July 29, 2014, Ulthera, Inc. operates as a subsidiary of Merz North America, Inc.

1840 South Stapley Drive

Suite 200

Mesa, AZ 85204

United States

Founded in 2004

153 Employees

Phone:

480-619-4069

Fax:

480-619-4071

Key Executives for Ulthera, Inc.

Chief Executive Officer, President and Director
Age: 62
Co-Founder and Director
Age: 67
Chief Financial Officer
Age: 65
Vice President of Operations
Age: 56
Principal Accounting Officer and Controller
Compensation as of Fiscal Year 2015.

Ulthera, Inc. Key Developments

Ulthera Inc. Receives FDA Clearance for Ultherapy Décolletage Treatment

Ulthera Inc. announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively treat the chest to improve lines and wrinkles of the décolleté. The Ultherapy Décolletage Treatment utilizes the System's signature imaging and micro-focused ultrasound therapy capabilities and takes about 30 minutes to administer. The Treatment stimulates the natural formation of collagen and elastin in the skin's foundation to gradually smooth chest wrinkles. Results are visible after about three months. As with the FDA-cleared Ultherapy procedure for lifting the neck, eyebrow and under the chin, meaningful results are achieved in just one treatment, and there's no downtime or post-treatment care requirements. The Ultherapy Décolletage Treatment will be available in more than 1,500 physician practices across the United States, starting third quarter 2014. The Treatment is already cleared in more than 40 other countries worldwide and has been selectively available since 2012.

Ulthera Appoints Marshall Mohr to Board of Directors

Ulthera Inc. announced that Marshall Mohr has joined its board of directors. Mohr is currently the Senior Vice President and Chief Financial Officer at Intuitive Surgical. Mohr serves on the boards of directors of Plantronics Inc. and Pacific Biosciences of California Inc.

Similar Private Companies By Industry

Company Name Region
Avalign Technologies, Inc. United States
HealthTell, Inc. United States
Kona Medical, Inc. United States
GE Healthcare Bio-Sciences Corp. United States
CONMED Endoscopic Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ulthera, Inc., please visit www.ulthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.